• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

March 27, 2013

View Archived Issues

Small-molecule antiviral agents target HIV-1 replication

Read More

AstraZeneca and Moderna Therapeutics to develop messenger RNA therapeutics

Read More

Bluebird bio enters collaboration with Celgene

Read More

H3 Biomedicine and BGI to develop and share cancer genomic sequencing data

Read More

Benefits demonstrated for onabotulinumtoxinA in patients with OAB

Read More

Novel QC inhibitor shows promise as AD therapy in a phase I trial

Read More

BioCryst Pharmaceuticals patents new tyrosine-protein kinase inhibitors

Read More

Acofide tablets approved in Japan for functional dyspepsia

Read More

Auxilium announces topline data from study of Xiaflex in frozen shoulder syndrome

Read More

TOP2A as an independent biomarker of NPC tumor aggressiveness

Read More

Inovelon approved in Japan for Lennox-Gastaut syndrome

Read More

Neuropore Therapeutics presents novel therapeutic candidate for neurological disorders

Read More

arGEN-X advances ARGX-112 into preclinical development

Read More

New agents for substance abuse and dependence divulged by Gilead Sciences

Read More

Shionogi receives approval for metreleptin in Japan

Read More

Shin Nippon Biomedical and Nagasaki University enter collaboration

Read More

Reversible covalent modification of KEAP1 as a promising approach for PD therapy

Read More

Onglyza approved in Japan for type 2 diabetes

Read More

BioCryst commences clinical study of candidate for hereditary angioedema

Read More

Lundbeck and Otsuka expand collaboration to include Lu-AE-58054

Read More

Shire gains lifitegrast with acquisition of SARcode Bioscience

Read More

Chugai gains Japanese approval for subcutaneous formulation of Actemra

Read More

Japanese authorities approve denosumab for osteoporosis

Read More

FDA approves botulism antitoxin manufactured by Cangene

Read More

GSK gives update on FDA's review of H5N1 adjuvanted influenza vaccine

Read More

Eisai set to launch neuromuscular-blocking agent in Japan for cervical dystonia

Read More

Bristol-Myers Squibb presents new series of anti-HIV agents

Read More

FDA approves Novartis' dry powder inhaled antibacterial Tobi Podhaler

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe